نتائج البحث - "Misgav, M"

1

Academic Journal

PB0627 Management of Invasive Procedures in Patients with Hemophilia A Receiving Emicizumab Prophylaxis: Real-World Data from a National Hemophilia Treatment Center

المؤلفون: Cohen, O., Budnik, I., Ludan, N., Kassia Lyskov, S., Efros, O., Lubetsky, A., Lalezari, S., Misgav, M., Kenet, G., Barg, A.

المصدر: Research and Practice in Thrombosis and Haemostasis ; volume 7, page 101203 ; ISSN 2475-0379

الاتاحة: http://dx.doi.org/10.1016/j.rpth.2023.101203
https://api.elsevier.com/content/article/PII:S2475037923048604?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2475037923048604?httpAccept=text/plain

View record in BASE

2

Academic Journal

Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial).

المؤلفون: Curry, N, Albayrak, C, Escobar, M, Andre Holme, P, Kearney, S, Klamroth, R, Misgav, M, Négrier, C, Wheeler, A, Santagostino, E, Shima, M, Landorph, A, Tønder, SM, Lentz, SR

Relation: https://ora.ox.ac.uk/objects/uuid:aebddc31-a49d-4f6c-9100-aedd83826685; https://doi.org/10.1111/hae.13712

الاتاحة: https://doi.org/10.1111/hae.13712
https://ora.ox.ac.uk/objects/uuid:aebddc31-a49d-4f6c-9100-aedd83826685

View record in BASE

3

Academic Journal

Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials

المؤلفون: Santagostino, E, Lentz, S R, Misgav, M, Brand, B, Chowdary, P, Savic, A, Kilinc, Y, Amit, Y, Amendola, A, Solimeno, L P, Saugstrup, T, Matytsina, I

المصدر: Santagostino, E; Lentz, S R; Misgav, M; Brand, B; Chowdary, P; Savic, A; Kilinc, Y; Amit, Y; Amendola, A; Solimeno, L P; Saugstrup, T; Matytsina, I (2015). Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. Haemophilia, 21(1):34-40.

مصطلحات موضوعية: Clinic for Oncology and Hematology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/120805/1/Santagostino_et_al-2015-Haemophilia.pdf; info:pmid/25273984; urn:issn:1351-8216

الاتاحة: https://www.zora.uzh.ch/id/eprint/120805/
https://doi.org/10.1111/hae.12518

View record in BASE

4

Academic Journal

Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight ® ) in previously treated patients with severe haemophilia A: interim results of the guardian ™ 2 extension trial

المؤلفون: Ozelo, M., Misgav, M., Abdul Karim, F., Lentz, S. R., Martin‐Salces, M., Matytsina, I., Saugstrup, T., Santagostino, E.

المساهمون: Novo Nordisk A/S

المصدر: Haemophilia ; volume 21, issue 5 ; ISSN 1351-8216 1365-2516

الاتاحة: http://dx.doi.org/10.1111/hae.12737
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fhae.12737
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12737
https://onlinelibrary.wiley.com/doi/full-xml/10.1111/hae.12737

View record in BASE

5

Academic Journal

Interim results from a large multinational extension trial (guardian ™ 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

المؤلفون: Lentz, S. R., Cerqueira, M., Janic, D., Kempton, C., Matytsina, I., Misgav, M., Oldenburg, J., Ozelo, M., Recht, M., Rosholm, A., Savic, A., Suzuki, T., Tiede, A., Santagostino, E.

المساهمون: Novo Nordisk, Baxter International, Bayer, Pfizer, Baxalta, Biogen, CSL Behring, F. Hoffmann-La Roche

المصدر: Haemophilia ; volume 22, issue 5 ; ISSN 1351-8216 1365-2516

الاتاحة: http://dx.doi.org/10.1111/hae.12990
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fhae.12990
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12990

View record in BASE

6

Academic Journal

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

المؤلفون: Lentz, S R, Misgav, M, Ozelo, M, Salek, S Z, Veljkovic, D, Recht, M, Cerqueira, Manuel, Tiede, A, Brand, B, Mancuso, M E, Seremetis, S, Lindblom, A, Martinowitz, U

المصدر: Lentz, S R; Misgav, M; Ozelo, M; Salek, S Z; Veljkovic, D; Recht, M; Cerqueira, Manuel; Tiede, A; Brand, B; Mancuso, M E; Seremetis, S; Lindblom, A; Martinowitz, U (2013). Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia, 19(5):691-697.

مصطلحات موضوعية: Clinic for Oncology and Hematology, 610 Medicine & health

Relation: https://www.zora.uzh.ch/87467; info:pmid/23647704; urn:issn:1351-8216

الاتاحة: https://www.zora.uzh.ch/id/eprint/87467/
https://www.zora.uzh.ch/87467
https://doi.org/10.1111/hae.12159

View record in BASE